EwaOlechMD
Rheumatology • Las Vegas, NVAssociate Professor, Internal Medicine, Las Vegas, University of Nevada School of Medicine
Dr. Olech is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cathedral Rock Dr
Ste 110
Las Vegas, NV 89128Phone+1 702-489-4838Fax+1 702-489-4838
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Rheumatology, 2003 - 2005
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 1999 - 2002
Medical University of LublinClass of 1994
Certifications & Licensure
NV State Medical License 2011 - 2025
OK State Medical License 2005 - 2025
IL State Medical License 1999 - 2014- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2007 Feb 01
- The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients Start of enrollment: 2010 Sep 01
- MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE Start of enrollment: 2017 Apr 10
Roles: Contact
Publications & Presentations
PubMed
- 29 citationsFavorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta‐analysisHamayon Babary, Xibei Liu, Yosef Ayatollahi, Xin P. Chen, Loomee Doo
International Journal of Rheumatic Diseases. 2017-09-08 - 12 citationsTwo-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid ...Alan Kivitz, Ewa Olech, Michael A Borofsky, Beatriz M Zazueta, Federico Navarro-Sarabia
The Journal of Rheumatology. 2017-12-15 - 114 citationsSubcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid ArthritisAlan Kivitz, Ewa Olech, Michael S. Borofsky, Beatriz M Zazueta, Federico Navarro-Sarabia
Arthritis Care & Research. 2014-11-01
Press Mentions
Top Doctors 2019August 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
